Dopamine and glutamate in attention deficit hyperactivity disorder

James M. Swanson; Nora D. Volkow; Jeffrey Newcorn; B. J. Casey; Robert Moyzis; David K. Grandy; Michael I. Posner

doi:10.1007/978-1-59259-852-6_13

Dopamine and glutamate in attention deficit hyperactivity disorder

James M. Swanson, Nora D. Volkow, Jeffrey Newcorn, B. J. Casey, Robert Moyzis, David K. Grandy, Michael I. Posner

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

2 Scopus citations

Abstract

Attention deficit hyperactivity disorder (ADHD) is a complex condition, thought to have multiple subtypes lurking within a broad, behaviorally defined phenotype, making it difficult to identify specific biological causes of this syndrome. However, the evidence from studies conducted over the past decade suggests that dopamine (DA) plays a prominent role in the etiology and treatment of ADHD. Here we will start with consensus views that have emerged about ADHD at the behavioral, biological, and genetic levels of analysis. Then, we will summarize the evidence that links DA to ADHD.

Original language	English
Title of host publication	Dopamine and Glutamate in Psychiatric Disorders
Publisher	Humana Press
Pages	293-315
Number of pages	23
ISBN (Print)	9781588293251
DOIs	https://doi.org/10.1007/978-1-59259-852-6_13
State	Published - 2005

Access to Document

10.1007/978-1-59259-852-6_13

Cite this

@inbook{984ffe8940ca47639db29d25032ef02b,

title = "Dopamine and glutamate in attention deficit hyperactivity disorder",

abstract = "Attention deficit hyperactivity disorder (ADHD) is a complex condition, thought to have multiple subtypes lurking within a broad, behaviorally defined phenotype, making it difficult to identify specific biological causes of this syndrome. However, the evidence from studies conducted over the past decade suggests that dopamine (DA) plays a prominent role in the etiology and treatment of ADHD. Here we will start with consensus views that have emerged about ADHD at the behavioral, biological, and genetic levels of analysis. Then, we will summarize the evidence that links DA to ADHD.",

author = "Swanson, {James M.} and Volkow, {Nora D.} and Jeffrey Newcorn and Casey, {B. J.} and Robert Moyzis and Grandy, {David K.} and Posner, {Michael I.}",

year = "2005",

doi = "10.1007/978-1-59259-852-6_13",

language = "English",

isbn = "9781588293251",

pages = "293--315",

booktitle = "Dopamine and Glutamate in Psychiatric Disorders",

publisher = "Humana Press",

address = "United States",

}

TY - CHAP

T1 - Dopamine and glutamate in attention deficit hyperactivity disorder

AU - Swanson, James M.

AU - Volkow, Nora D.

AU - Newcorn, Jeffrey

AU - Casey, B. J.

AU - Moyzis, Robert

AU - Grandy, David K.

AU - Posner, Michael I.

PY - 2005

Y1 - 2005

N2 - Attention deficit hyperactivity disorder (ADHD) is a complex condition, thought to have multiple subtypes lurking within a broad, behaviorally defined phenotype, making it difficult to identify specific biological causes of this syndrome. However, the evidence from studies conducted over the past decade suggests that dopamine (DA) plays a prominent role in the etiology and treatment of ADHD. Here we will start with consensus views that have emerged about ADHD at the behavioral, biological, and genetic levels of analysis. Then, we will summarize the evidence that links DA to ADHD.

AB - Attention deficit hyperactivity disorder (ADHD) is a complex condition, thought to have multiple subtypes lurking within a broad, behaviorally defined phenotype, making it difficult to identify specific biological causes of this syndrome. However, the evidence from studies conducted over the past decade suggests that dopamine (DA) plays a prominent role in the etiology and treatment of ADHD. Here we will start with consensus views that have emerged about ADHD at the behavioral, biological, and genetic levels of analysis. Then, we will summarize the evidence that links DA to ADHD.

UR - http://www.scopus.com/inward/record.url?scp=84891461771&partnerID=8YFLogxK

U2 - 10.1007/978-1-59259-852-6_13

DO - 10.1007/978-1-59259-852-6_13

M3 - Chapter

AN - SCOPUS:84891461771

SN - 9781588293251

SP - 293

EP - 315

BT - Dopamine and Glutamate in Psychiatric Disorders

PB - Humana Press

ER -

Dopamine and glutamate in attention deficit hyperactivity disorder

Abstract

Access to Document

Fingerprint

Cite this